Skip to main content

Advertisement

Log in

Early recurrent ischemic events after mechanical thrombectomy: effect of post-treatment intracranial hemorrhage

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Objective

Patients with intracranial hemorrhages (ICH) after mechanical thrombectomy (MT) may have a higher risk of early recurrent embolism (ERE) because of delayed initiation of anticoagulants. We assessed the rate of ischemic events in the early period after MT and the association with post-MT ICH.

Methods

Patients who underwent MT in our institute were retrospectively reviewed. ERE was defined as recurrent ischemic stroke and systemic embolism within 14 days after MT. The association between ERE and parenchymal hematoma (PH) was assessed. Multivariable regression analysis and inverse probability of treatment weighting was used to adjust for differences in baseline characteristics between patients with and without PH.

Results

A total of 307 patients (median age, 78 years; female, 47%; median baseline National Institutes of Health Stroke Scale score, 19) were included. ERE was observed in 12 of 307 patients (8 strokes, 4 systemic embolisms; 3.9%). Median time from MT to ERE was 6.5 days (IQR, 3–8 days). PH occurred in 21 patients (6.8%). Median time from MT to initiating oral anticoagulants was longer in patients with PH (8 days) than in those without (3 days) (p < 0.01). In both unweighted and weighted multivariable analysis, PH was significantly associated with an increased risk of ERE (unweighted odds ratio, 10.60; 95% CI, 2.66–42.23; weighted odds ratio, 12.34; 95% CI, 2.49–61.07).

Conclusions

ERE occurred in about 4% of patients after MT. PH after MT was associated with delayed initiation of oral anticoagulants and an increased risk of recurrent ischemic events.

Clinical trial registration

URL: https://www.clinicaltrials.gov. Unique identifier: NCT02251665.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of data and material

A part, not all, of patients’ data may be available upon reasonable request.

References

  1. Goyal M, Menon BK, van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387:1723–1731

    Article  Google Scholar 

  2. Pirson FAV, van Oostenbrugge RJ, van Zwam WH, Remmers MJM, Dippel DWJ, van Es A et al (2020) Repeated endovascular thrombectomy in patients with acute ischemic stroke: results from a nationwide multicenter database. Stroke 51:526–532

    Article  Google Scholar 

  3. Emprechtinger R, Piso B, Ringleb PA (2017) Thrombectomy for ischemic stroke: meta-analyses of recurrent strokes, vasospasms, and subarachnoid hemorrhages. J Neurol 264:432–436

    Article  Google Scholar 

  4. Abdul-Rahim AH, Fulton RL, Frank B, Tatlisumak T, Paciaroni M, Caso V et al (2015) Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA. Eur J Neurol 22:1048–1055

    Article  CAS  Google Scholar 

  5. Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S et al (2015) Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study. Stroke 46:2175–2182

    Article  CAS  Google Scholar 

  6. Nogueira RG, Gupta R, Jovin TG, Levy EI, Liebeskind DS, Zaidat OO et al (2015) Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients. J Neurointerv Surg 7:16–21

    Article  Google Scholar 

  7. Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL et al (2013) Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 44:2650–2663

    Article  Google Scholar 

  8. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272

    Article  Google Scholar 

  9. Barber PA, Demchuk AM, Zhang J, Buchan AM (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 355:1670–1674

    Article  CAS  Google Scholar 

  10. Tei H, Uchiyama S, Usui T, Ohara K (2010) Posterior circulation aspects on diffusion-weighted MRI can be a powerful marker for predicting functional outcome. J Neurol 257:767–773

    Article  Google Scholar 

  11. Toyoda K, Arihiro S, Todo K, Yamagami H, Kimura K, Furui E et al (2015) Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in japan: the SAMURAI-NVAF study. Int J Stroke 10:836–842

    Article  Google Scholar 

  12. von Kummer R, Broderick JP, Campbell BC, Demchuk A, Goyal M, Hill MD et al (2015) The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke 46:2981–2986

    Article  Google Scholar 

  13. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317–1329

    Article  CAS  Google Scholar 

  14. Strobl C, Boulesteix A-L, Kneib T, Augustin T, Zeileis A (2008) Conditional variable importance for random forests. BMC Bioinformatics 9:307

    Article  Google Scholar 

  15. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372:1019–1030

    Article  CAS  Google Scholar 

  16. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A et al (2015) Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372:2296–2306

    Article  CAS  Google Scholar 

  17. Yasaka M, Minematsu K, Toyoda K, Mori E, Hirano T, Hamasaki T et al (2019) Rivaroxaban administration after acute ischemic stroke: the RELAXED study. PLoS ONE 14:e0212354

    Article  CAS  Google Scholar 

  18. Koga M (2018) More benefits from endovascular thrombectomy in patients with atrial fibrillation. Circ J 82:2483–2484

    Article  Google Scholar 

  19. Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W et al (2015) Updated european heart rhythm association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17:1467–1507

    Article  Google Scholar 

  20. Seiffge DJ, Paciaroni M, Wilson D, Koga M, Macha K, Cappellari M et al (2019) Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation. Ann Neurol 85:823–834

    Article  CAS  Google Scholar 

  21. Murthy SB, Diaz I, Wu X, Merkler AE, Iadecola C, Safford MM et al (2020) Risk of arterial ischemic events after intracerebral hemorrhage. Stroke 51:137–142

    Article  Google Scholar 

  22. Boisseau W, Fahed R, Lapergue B, Desilles JP, Zuber K, Khoury N et al (2019) Predictors of parenchymal hematoma after mechanical thrombectomy: a multicenter study. Stroke 50:2364–2370

    Article  Google Scholar 

  23. Lee YB, Yoon W, Lee YY, Kim SK, Baek BH, Kim JT et al (2019) Predictors and impact of hemorrhagic transformations after endovascular thrombectomy in patients with acute large vessel occlusions. J Neurointerv Surg 11:469–473

    Article  Google Scholar 

  24. Ducroux C, Piotin M, Gory B, Labreuche J, Blanc R, Ben Maacha M et al (2020) First pass effect with contact aspiration and stent retrievers in the aspiration versus stentretriever (ASTER) trial. J Neurointerv Surg 12:386–391

    Article  Google Scholar 

Download references

Funding

This study was supported in part by a Grant-in-Aid for Scientific Research (20K16716).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Junpei Koge.

Ethics declarations

Conflicts of interest

Dr. Koge reports no disclosures. Dr. Tanaka reports lecturer’s fees from Daiichi-Sankyo, Medico’s Hirata, and Stryker. Dr. Yoshimoto reports lecture’s fees from Takeda Pharmaceutical. Dr. Shiozawa reports no disclosures. Dr. Yamagami reports research grants from Bristol-Myers Squibb; lecturer’s fees from Stryker, Terumo, Medtronic, Medico’s Hirata, Johnson and Johnson, Bayer, Daiichi-Sankyo, Bristol-Myers Squibb, Boehringer Ingelheim, Takeda, and Otsuka Pharmaceutical; and membership of the advisory boards for Daiichi-Sankyo and Biomedical Solutions. Dr. Satow reports research funding from CANON Medical System, lecture’s fees from Medtronic and Stryker. Dr. Takahashi reports no disclosures. Dr. Ihara reports lecturer’s fees from Daiichi Sankyo, Eisai, and Bayer, and grant support from Panasonic, Bristol-Myers Squibb, and Otsuka Pharmaceutical. Dr. Koga reports honoraria from Bayer Yakuhin, Bristol-Myers-Squibb, Otsuka, Daiichi-Sankyo, Nippon Boehringer Ingelheim and Takeda, scientific advisory board from Ono, and research supports from Takeda, Daiichi-Sankyo, Nippon Boehringer Ingelheim, Astellas, Pfizer and Shionogi, outside the submitted work. Dr. Kira reports no disclosures. Dr. Toyoda reports lecturer’s fees from Daiichi Sankyo, Boehringer Ingelheim, Bayer, and Bristol-Myers Squibb.

Ethics approval

This study was approved by the ethics committee of the National Cerebral and Cardiovascular Center, Japan (M23-073-7).

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 484 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koge, J., Tanaka, K., Yoshimoto, T. et al. Early recurrent ischemic events after mechanical thrombectomy: effect of post-treatment intracranial hemorrhage. J Neurol 268, 2810–2820 (2021). https://doi.org/10.1007/s00415-021-10449-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-021-10449-1

Keywords

Navigation